PI3Kγ deletion reduces variability in the in vivo osteolytic response induced by orthopaedic wear particles

Journal of Orthopaedic Research

Volumn 29, Issue 11, 2011, Pages 1649-1653

  Greenfield, Edward M ^a,b   Tatro, Joscelyn M ^a   Smith, Matthew V ^c   Schnaser, Erik A ^a   Wu, Dianqing ^d,e  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d YALE UNIVERSITY   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

aseptic loosening; PI3K; titanium

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE GAMMA; POLYETHYLENE; TITANIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALVARIA; CONTROLLED STUDY; FEMALE; GENE DELETION; IN VIVO STUDY; INFLAMMATION; MICRORADIOGRAPHY; MOUSE; NONHUMAN; ORTHOPEDIC PROSTHESIS; OSTEOLYSIS; PRIORITY JOURNAL; SKULL RADIOGRAPHY; SKULL SUTURE; WILD TYPE;

ANIMALS; CLASS IB PHOSPHATIDYLINOSITOL 3-KINASE; FEMALE; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; OSTEITIS; OSTEOLYSIS; PARIETAL BONE; POLYETHYLENE; PROSTHESIS FAILURE; SIGNAL TRANSDUCTION; TITANIUM;

EID: 80053199751     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21440     Document Type: Article

References (41)

1. Ingham E, Fisher J,. 2005. The role of macrophages in osteolysis of total joint replacement. Biomaterials 26: 1271-1286. (Pubitemid 39314501)
2. Greenfield EM, Bi Y, Ragab AA, et al. 2002. The role of osteoclast differentiation in aseptic loosening. J Orthop Res 20: 1-8. (Pubitemid 34071414)
3. Holt G, Murnaghan C, Reilly J, et al. 2007. The biology of aseptic osteolysis. Clin Orthop Relat Res 460: 240-252. (Pubitemid 47056504)
4. Nakashima Y, Sun DH, Trindade MC, et al. 1999. Signaling pathways for tumor necrosis factor-a and interluekin-6 expression in human macrophages exposed to titanium-alloy particulate debris in vitro. J Bone Joint Surg 81A: 603-615. (Pubitemid 29241254)
5. Schwarz EM, Lu AP, Goater JJ, et al. 2000. Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis. J Orthop Res 18: 472-480. (Pubitemid 30599625)
6. Akisue T, Bauer TW, Farver CF, et al. 2002. The effect of particle wear debris on NFkappaB activation and pro-inflammatory cytokine release in differentiated THP-1 cells. J Biomed Mater Res 259: 507-515. (Pubitemid 34037495)
7. Abbas S, Clohisy JC, Abu-Amer Y,. 2003. Mitogen-activated protein (MAP) kinases mediate PMMA-induction of osteoclasts. J Orthop Res 21: 1041-1048. (Pubitemid 37322386)
8. Clohisy JC, Hirayama T, Frazier E, et al. 2004. NF-κB signaling blockade abolishes implant particle-induced osteoclastogenesis. J Orthop Res 22: 13-20. (Pubitemid 38035440)
9. Seo SW, Lee D, Cho SK, et al. 2007. ERK signaling regulates macrophage colony-stimulating factor expression induced by titanium particles in MC3T3.E1 murine calvarial preosteoblastic cells. Ann N Y Acad Sci 1117: 151-158. (Pubitemid 350191272)
10. Beidelschies M, Huang H, McMullen M, et al. 2008. Stimulation of macrophage TNFa production by orthopaedic wear particles requires activation of the ERK1/2/Egr-1 and NF-κB pathways but is independent of p38 and JNK. J Cell Physiol 217: 652-666.
11. Smith M, Lee M, Islam A, et al. 2007. The PI3K/Akt pathway mediates the biological response to titanium particles. J Bone Joint Surg 89A: 1019-1027.
12. Koyasu S,. 2003. The role of PI3K in immune cells. Nat Immunol 4: 313-319.
13. Li Z, Jiang H, Xie W, et al. 2000. Roles of PLC-beta2 and-beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. Science 287: 1046-1049. (Pubitemid 30094361)
14. Hirsch E, Katanaev VL, Garlanda C, et al. 2000. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 287: 1049-1053.
15. Rommel C, Camps M, Ji H,. 2007. PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond ? Nat Rev Immunol 7: 191-201.
16. Barber DF, Bartolome A, Hernandez C, et al. 2005. PI3Kγ inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus. Nat Med 11: 933-935. (Pubitemid 41294437)
17. Camps M, Ruckle T, Ji H, et al. 2005. Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med 11: 936-943. (Pubitemid 41294438)
18. Barber DF, Bartolome A, Hernandez C, et al. 2006. Class IB-phosphatidylinositol 3-kinase (PI3K) deficiency ameliorates IA-PI3K-induced systemic lupus but not T cell invasion. J Immunol 176: 589-593. (Pubitemid 43023307)
19. Kang H, Chang W, Hurley M, et al. 2010. Important roles of PI3K{gamma} in osteoclastogenesis and bone homeostasis. Proc Natl Acad Sci USA 107: 12901-12906.
20. Kaar SG, Ragab AA, Kaye SJ, et al. 2001. Rapid repair of titanium particle-induced osteolysis is dramatically reduced in aged mice. J Orthop Res 19: 171-178. (Pubitemid 32331689)
21. Ragab AA, Van De Motter R, Lavish SA, et al. 1999. Measurement and removal of adherent endotoxin from titanium particles and implant surfaces. J Orthop Res 17: 803-809. (Pubitemid 30033279)
22. Taki N, Tatro JM, Nalepka JL, et al. 2005. Polyethylene and titanium particles induce osteolysis by similar, lymphocyte-independent, mechanisms. J Orthop Res 23: 376-383. (Pubitemid 40287864)
23. Taki N, Tatro J, Lowe R, et al. 2007. Comparison of the roles of IL-1, IL-6, and TNFa in cell culture and murine models of aseptic loosening. Bone 40: 1276-1283. (Pubitemid 46550971)
24. Bi Y, Seabold JM, Kaar SC, et al. 2001. Adherent endotoxin on orthopaedic wear particles stimulates cytokine production and osteoclast differentiation. J Bone Min Res 16: 2082-2091. (Pubitemid 32995400)
25. Tatro J, Taki N, Islam A, et al. 2007. The balance between endotoxin accumulation and clearance during particle-induced osteolysis in murine calvaria. J Orthop Res 25: 361-369. (Pubitemid 46455907)
26. McGee-Lawrence ME, Westendorf JJ,. 2011. Histone deacetylases in skeletal development and bone mass maintenance. Gene 474: 1-11.
27. Pike JW,. 2011. Genome-scale techniques highlight the epigenome and redefine fundamental principles of gene regulation. J Bone Miner Res (in press).
28. Wilkinson JM, Hamer AJ, Stockley I, et al. 2005. Polyethylene wear rate and osteolysis: critical threshold versus continuous dose-response relationship. J Orthop Res 23: 520-525. (Pubitemid 40631321)
29. Gordon A, Greenfield E, Eastell R, et al. 2010. Individual susceptibility to periprosthetic osteolysis is associated with elevated innate immune responses to pro-inflammatory stimuli. J Orthop Res 28: 1127-1135.
30. Yue P, Forrest WF, Kaminker JS, et al. 2010. Inferring the functional effects of mutation through clusters of mutations in homologous proteins. Hum Mutat 31: 264-271.
31. O'Neill L, Bowie A,. 2007. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 7: 353-364. (Pubitemid 46674493)
32. Bi Y, Collier TO, Goldberg VM, et al. 2002. Adherent endotoxin mediates biological responses of titanium particles without stimulating their phagocytosis. J Orthop Res 20: 696-703. (Pubitemid 34822988)
33. Greenfield E, Beidelschies M, Tatro J, et al. 2010. Bacterial pathogen-associated molecular patterns stimulate biological activity of orthopaedic were particles by activating cognate Toll-like receptors. J Biol Chem 285: 32378-32384.
34. Li N, Nakamura K, Jiang Y, et al. 2004. Gain-of-function polymorphism in mouse and human Ltk: implications for the pathogenesis of systemic lupus erythematosus. Hum Mol Genet 13: 171-179. (Pubitemid 38111355)
35. Graham RR, Hom G, Ortmann W, et al. 2009. Review of recent genome-wide association scans in lupus. J Intern Med 265: 680-688.
36. Theofilopoulos AN, Gonzalez-Quintial R, Lawson BR, et al. 2010. Sensors of the innate immune system: their link to rheumatic diseases. Nat Rev Rheumatol 6: 146-156.
37. Zuo T, Liu TM, Lan X, et al. 2011. Epigenetic silencing mediated through activated PI3K/AKT signaling in breast cancer. Cancer Res 71: 1752-1762.
38. Wilkinson JM, Wilson A, Stockley I, et al. 2003. Variation in the TNF gene promoter and risk of osteolysis after total hip arthroplasty. J Bone Min Res 18: 1995-2001. (Pubitemid 37377449)
39. Gordon A, Kiss-Toth E, Stockley I, et al. 2008. Polymorphisms in the interleukin-1 receptor antagonist and interleukin-6 genes affect risk of osteolysis in patients with total hip arthroplasty. Arthritis Rheum 58: 3157-3165.
40. Gordon A, Southam L, Loughlin J, et al. 2007. Variation in the secreted frizzled-related protein-3 gene and risk of Osteolysis and heterotopic ossification after total hip arthroplasty. J Orthop Res 25: 1665-1670. (Pubitemid 350293815)
41. Gallo J, Mrazek F, Petrek M,. 2009. Variation in cytokine genes can contribute to severity of acetabular osteolysis and risk for revision in patients with ABG 1 total hip arthroplasty: a genetic association study. BMC Med Genet 10: 109.